4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1,410.00p
   
  • Change Today:
    -25.00p
  • 52 Week High: 1,470.00
  • 52 Week Low: 500.00
  • Currency: UK Pounds
  • Shares Issued: 12.81m
  • Volume: 6,199
  • Market Cap: £180.55m

Regulatory News

4basebio Plc - Director/PDMR Shareholding 12-May-2022 14:27 PR Newswire
4basebio Plc - Director/PDMR Shareholding 11-May-2022 11:57 PR Newswire
4basebio Plc - Final Result and Notice of AGM 09-May-2022 07:00 PR Newswire
Price Monitoring Extension 06-May-2022 14:00 RNS
4basebio Plc - Joint Development Agreement with ... 27-Apr-2022 07:00 PR Newswire
4basebio Plc - Rapidly Produced Customisable Syn... 23-Mar-2022 07:00 PR Newswire
Second Price Monitoring Extn 15-Mar-2022 16:41 RNS
Price Monitoring Extension 15-Mar-2022 16:35 RNS
Second Price Monitoring Extn 15-Mar-2022 14:05 RNS
Price Monitoring Extension 15-Mar-2022 14:01 RNS
Price Monitoring Extension 15-Mar-2022 11:00 RNS
Price Monitoring Extension 15-Mar-2022 09:00 RNS
Second Price Monitoring Extn 08-Mar-2022 09:05 RNS
Price Monitoring Extension 08-Mar-2022 09:00 RNS
4basebio Plc - DNA manufacturing update 15-Feb-2022 07:00 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4basebio Market Data

Currency UK Pounds
Share Price 1,410.00p
Change Today -25.00p
% Change -1.74 %
52 Week High 1,470.00
52 Week Low 500.00
Volume 6,199
Shares Issued 12.81m
Market Cap £180.55m

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
71.16% below the market average71.16% below the market average71.16% below the market average71.16% below the market average71.16% below the market average
29.41% below the sector average29.41% below the sector average29.41% below the sector average29.41% below the sector average29.41% below the sector average
Price Trend
99.88% above the market average99.88% above the market average99.88% above the market average99.88% above the market average99.88% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income Not Available
Growth
34.71% below the market average34.71% below the market average34.71% below the market average34.71% below the market average34.71% below the market average
47.06% below the sector average47.06% below the sector average47.06% below the sector average47.06% below the sector average47.06% below the sector average

4basebio Dividends

No dividends found

Trades for 17-May-2024

Time Volume / Share Price
15:01 1,000 @ 1,420.00p
16:17 70 @ 1,419.00p
16:16 70 @ 1,419.00p
15:06 423 @ 1,414.00p
15:02 500 @ 1,450.00p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page